Title : S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancer.

Pub. Date : 2009 Jul

PMID : 19632949






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 S-1 (also known as TS-1; Taiho Pharmaceutical Co. Ltd.; Tokyo, Japan) is a new oral fluoropyrimidine formulation that combines tegafur, 5-chloro-2,4-dihydroxypyridine (CDHP), and potassium oxonate in a molar ratio of 1:0.4:1. Tegafur proteasome 26S subunit, non-ATPase 1 Homo sapiens